BCL2 and cancer: Evidence of the impact of computational modeling in cancer therapeutics is the fact that our multiscale mathematical model of the VEGF-CXCL8-BCL-2 pathway suggested that metronomic dosing of a SMI of BCl-2 could provide optimal efficacy [13].